Home › COPD › Alabama › Birmingham
COPD klinische studies in Birmingham, AL
17 studies voor COPD zoeken deelnemers op locaties in en rond Birmingham (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekruterenFase 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruterenFase 2
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
RekruterenFase 4
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RekruterenFase 2
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RekruterenFase 2
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
RekruterenFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RekruterenFase 2/3
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RekruterenFase 3
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
RekruterenObservatieonderzoek
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
RekruterenFase 3
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Rekruteren
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Rekruteren
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Rekruteren
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
RekruterenObservatieonderzoek
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
RekruterenFase 4
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Rekruteren
- UAB School of Medicine/Lung Health Center, Birmingham
COPD studies in andere steden
- Philadelphia, PA23 studies
- Miami, FL18 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Baltimore, MD14 studies
- Chicago, IL14 studies
- Dallas, TX12 studies
- Pittsburgh, PA12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Winston-Salem, NC9 studies
Andere studies in Birmingham
- Kanker (alle vormen)30 studies
- Borstkanker24 studies
- Obesitas23 studies
- Eierstokkanker23 studies
- Niet-kleincellige longkanker22 studies
- Acute myeloïde leukemie21 studies
- Multipel myeloom18 studies
- Cardiovasculaire ziekte17 studies
- Overgewicht16 studies
- Endometriumkanker16 studies
- Type 2-diabetes16 studies
- Cystische fibrose16 studies
Van ClinicalTrials.gov, gegevens opgehaald op 4 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.